135 related articles for article (PubMed ID: 1581459)
1. [An update on the clinical and pathogenetic value of a lymphocyte subpopulation study in systemic lupus erythematosus].
López-Gómez M; Sampalo Lainz A; Jiménez-Alonso J
An Med Interna; 1992 Apr; 9(4):200-4. PubMed ID: 1581459
[TBL] [Abstract][Full Text] [Related]
2. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subsets in systemic lupus erythematosus.
Cheong SK; Chin SF; Kong NC
Malays J Pathol; 1997 Dec; 19(2):121-5. PubMed ID: 10879252
[TBL] [Abstract][Full Text] [Related]
4. Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
Robak E; Błoński JZ; Bartkowiak J; Niewiadomska H; Sysa-Jedrzejowska A; Robak T
Mediators Inflamm; 1999; 8(6):305-12. PubMed ID: 10815619
[TBL] [Abstract][Full Text] [Related]
5. CD134 expression on CD4+ T cells is associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Patschan S; Dolff S; Kribben A; Dürig J; Patschan D; Wilde B; Specker C; Philipp T; Witzke O
Clin Exp Immunol; 2006 Aug; 145(2):235-42. PubMed ID: 16879242
[TBL] [Abstract][Full Text] [Related]
6. Peripheral circulating activated b-cell populations are associated with nephritis and disease activity in patients with systemic lupus erythematosus.
Dolff S; Wilde B; Patschan S; Dürig J; Specker C; Philipp T; Kribben A; Witzke O
Scand J Immunol; 2007 Nov; 66(5):584-90. PubMed ID: 17868260
[TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapy of systemic lupus erythematosus.
Francis L; Perl A
Expert Opin Pharmacother; 2009 Jun; 10(9):1481-94. PubMed ID: 19505215
[TBL] [Abstract][Full Text] [Related]
8. Cellular immunity in systemic lupus erythematosus.
Boumpas DT; Eleftheriades EG; Tsokos GC
In Vivo; 1988; 2(1):41-5. PubMed ID: 2979815
[TBL] [Abstract][Full Text] [Related]
9. Do elevated levels of serum-soluble fas contribute to the persistence of activated lymphocytes in systemic lupus erythematosus?
Bijl M; van Lopik T; Limburg PC; Spronk PE; Jaegers SM; Aarden LA; Smeenk RJ; Kallenberg GG
J Autoimmun; 1998 Oct; 11(5):457-63. PubMed ID: 9802929
[TBL] [Abstract][Full Text] [Related]
10. A killing defect of natural killer cells as an underlying immunologic abnormality in childhood systemic lupus erythematosus.
Yabuhara A; Yang FC; Nakazawa T; Iwasaki Y; Mori T; Koike K; Kawai H; Komiyama A
J Rheumatol; 1996 Jan; 23(1):171-7. PubMed ID: 8838528
[TBL] [Abstract][Full Text] [Related]
11. Patients with systemic lupus erythematosus differ from healthy controls in their immunological response to acute psychological stress.
Pawlak CR; Jacobs R; Mikeska E; Ochsmann S; Lombardi MS; Kavelaars A; Heijnen CJ; Schmidt RE; Schedlowski M
Brain Behav Immun; 1999 Dec; 13(4):287-302. PubMed ID: 10600217
[TBL] [Abstract][Full Text] [Related]
12. B cell activity and regulatory T cell function in systemic lupus erythematosus by human B cell colony formation.
Otsuka T; Okamura S; Niho Y; Kusaba T
J Rheumatol; 1985 Jun; 12(3):508-13. PubMed ID: 2864442
[TBL] [Abstract][Full Text] [Related]
13. Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.
Dhir V; Singh AP; Aggarwal A; Naik S; Misra R
Lupus; 2009 Aug; 18(9):785-91. PubMed ID: 19578102
[TBL] [Abstract][Full Text] [Related]
14. Alterations of dendritic cells in systemic lupus erythematosus: phenotypic and functional deficiencies.
Scheinecker C; Zwölfer B; Köller M; Männer G; Smolen JS
Arthritis Rheum; 2001 Apr; 44(4):856-65. PubMed ID: 11315925
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus.
Tsokos GC; Magrath IT; Balow JE
J Immunol; 1983 Oct; 131(4):1797-801. PubMed ID: 6311898
[TBL] [Abstract][Full Text] [Related]
16. [Role of T and B lymphocytes in the pathogenesis of systemic lupus erythematosus].
Gliński W
Przegl Dermatol; 1976; 63(4):505-12. PubMed ID: 788057
[No Abstract] [Full Text] [Related]
17. Anti-lymphocyte antibodies in systemic lupus erythematosus.
Winfield JB
Clin Rheum Dis; 1985 Dec; 11(3):523-49. PubMed ID: 3907954
[TBL] [Abstract][Full Text] [Related]
18. Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.
Messner RP; Lindström FD; Williams RC
J Clin Invest; 1973 Dec; 52(12):3046-56. PubMed ID: 4584345
[TBL] [Abstract][Full Text] [Related]
19. [B-lymphocyte hyperreactivity and differentiation factors of T-lymphocytes in systemic lupus erythematosus].
Humbert M; Galanaud P
Ann Med Interne (Paris); 1990; 141(3):213-6. PubMed ID: 2369009
[TBL] [Abstract][Full Text] [Related]
20. Increase in activated CD8+ T lymphocytes expressing perforin and granzyme B correlates with disease activity in patients with systemic lupus erythematosus.
Blanco P; Pitard V; Viallard JF; Taupin JL; Pellegrin JL; Moreau JF
Arthritis Rheum; 2005 Jan; 52(1):201-11. PubMed ID: 15641052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
